UBS Maintains Neutral on Intuitive Surgical, Lowers Price Target to $550

Benzinga Newsdesk www.benzinga.com Negative 82.6%

Neg 82.6% Neu 0% Pos 0%

UBS analyst Andre Salles maintains Intuitive Surgical (NASDAQ:ISRG) with a Neutral and lowers the price target from $570 to $550.